Cellular immune responses to four doses of percutaneous bacille calmetteguerin in healthy adults

Philip W. Lowry, Teresa S. Ludwig, Jeffrey A. Adams, Michael L. Fitzpatrick, Suzanne M. Grant, Greg A. Andrle, Matthew R. Offerdahl, Sangnae Cho, David R. Jacobs

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

To explore the hypothesis that low-dose immunization might induce preferential Th1 cell immunity, 76 adults were vaccinated with one of four doses of bacille Calmette-Guerin (BCG): The doses contained very low (1.6 x 10 5 cfu), low (3.2 x l0 6 cfu), standard (1.6 x 10 8 cfu), or high (3.2 X 10 8 cfu) levels of BCG. Delayed-type hypersensitivity responses occurred 8 weeks after vaccination in 10% of persons given very low or low doses of BCG, compared with 95% and 100% of persons given standard or high doses, respectively. Lymphoproliferative responses, which were increased only for high-dose vaccinees, peaked 2 weeks after vaccination and were directed chiefly against Mycobacterium tuberculosis-secreted proteins, particularly the antigen 85 complex. Significant increases in mycobacteria-specific interferon-γ expression were present 16 weeks after vaccination only for persons given standard or high doses of BCG. Percutaneous BCG appears capable of inducing a temporary Th1-like immune response, but standard or higher dosages are required.

Original languageEnglish
Pages (from-to)138-146
Number of pages9
JournalJournal of Infectious Diseases
Volume178
Issue number1
DOIs
Publication statusPublished - 1998 Jan 1

Fingerprint

Cellular Immunity
Vaccination
Th1 Cells
Delayed Hypersensitivity
Mycobacterium
Mycobacterium tuberculosis
Interferons
Immunity
Immunization
Antigens
Proteins

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Lowry, P. W., Ludwig, T. S., Adams, J. A., Fitzpatrick, M. L., Grant, S. M., Andrle, G. A., ... Jacobs, D. R. (1998). Cellular immune responses to four doses of percutaneous bacille calmetteguerin in healthy adults. Journal of Infectious Diseases, 178(1), 138-146. https://doi.org/10.1086/515614
Lowry, Philip W. ; Ludwig, Teresa S. ; Adams, Jeffrey A. ; Fitzpatrick, Michael L. ; Grant, Suzanne M. ; Andrle, Greg A. ; Offerdahl, Matthew R. ; Cho, Sangnae ; Jacobs, David R. / Cellular immune responses to four doses of percutaneous bacille calmetteguerin in healthy adults. In: Journal of Infectious Diseases. 1998 ; Vol. 178, No. 1. pp. 138-146.
@article{1c98c233a9aa460a913b9baebc2edb25,
title = "Cellular immune responses to four doses of percutaneous bacille calmetteguerin in healthy adults",
abstract = "To explore the hypothesis that low-dose immunization might induce preferential Th1 cell immunity, 76 adults were vaccinated with one of four doses of bacille Calmette-Guerin (BCG): The doses contained very low (1.6 x 10 5 cfu), low (3.2 x l0 6 cfu), standard (1.6 x 10 8 cfu), or high (3.2 X 10 8 cfu) levels of BCG. Delayed-type hypersensitivity responses occurred 8 weeks after vaccination in 10{\%} of persons given very low or low doses of BCG, compared with 95{\%} and 100{\%} of persons given standard or high doses, respectively. Lymphoproliferative responses, which were increased only for high-dose vaccinees, peaked 2 weeks after vaccination and were directed chiefly against Mycobacterium tuberculosis-secreted proteins, particularly the antigen 85 complex. Significant increases in mycobacteria-specific interferon-γ expression were present 16 weeks after vaccination only for persons given standard or high doses of BCG. Percutaneous BCG appears capable of inducing a temporary Th1-like immune response, but standard or higher dosages are required.",
author = "Lowry, {Philip W.} and Ludwig, {Teresa S.} and Adams, {Jeffrey A.} and Fitzpatrick, {Michael L.} and Grant, {Suzanne M.} and Andrle, {Greg A.} and Offerdahl, {Matthew R.} and Sangnae Cho and Jacobs, {David R.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1086/515614",
language = "English",
volume = "178",
pages = "138--146",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "1",

}

Lowry, PW, Ludwig, TS, Adams, JA, Fitzpatrick, ML, Grant, SM, Andrle, GA, Offerdahl, MR, Cho, S & Jacobs, DR 1998, 'Cellular immune responses to four doses of percutaneous bacille calmetteguerin in healthy adults', Journal of Infectious Diseases, vol. 178, no. 1, pp. 138-146. https://doi.org/10.1086/515614

Cellular immune responses to four doses of percutaneous bacille calmetteguerin in healthy adults. / Lowry, Philip W.; Ludwig, Teresa S.; Adams, Jeffrey A.; Fitzpatrick, Michael L.; Grant, Suzanne M.; Andrle, Greg A.; Offerdahl, Matthew R.; Cho, Sangnae; Jacobs, David R.

In: Journal of Infectious Diseases, Vol. 178, No. 1, 01.01.1998, p. 138-146.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cellular immune responses to four doses of percutaneous bacille calmetteguerin in healthy adults

AU - Lowry, Philip W.

AU - Ludwig, Teresa S.

AU - Adams, Jeffrey A.

AU - Fitzpatrick, Michael L.

AU - Grant, Suzanne M.

AU - Andrle, Greg A.

AU - Offerdahl, Matthew R.

AU - Cho, Sangnae

AU - Jacobs, David R.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - To explore the hypothesis that low-dose immunization might induce preferential Th1 cell immunity, 76 adults were vaccinated with one of four doses of bacille Calmette-Guerin (BCG): The doses contained very low (1.6 x 10 5 cfu), low (3.2 x l0 6 cfu), standard (1.6 x 10 8 cfu), or high (3.2 X 10 8 cfu) levels of BCG. Delayed-type hypersensitivity responses occurred 8 weeks after vaccination in 10% of persons given very low or low doses of BCG, compared with 95% and 100% of persons given standard or high doses, respectively. Lymphoproliferative responses, which were increased only for high-dose vaccinees, peaked 2 weeks after vaccination and were directed chiefly against Mycobacterium tuberculosis-secreted proteins, particularly the antigen 85 complex. Significant increases in mycobacteria-specific interferon-γ expression were present 16 weeks after vaccination only for persons given standard or high doses of BCG. Percutaneous BCG appears capable of inducing a temporary Th1-like immune response, but standard or higher dosages are required.

AB - To explore the hypothesis that low-dose immunization might induce preferential Th1 cell immunity, 76 adults were vaccinated with one of four doses of bacille Calmette-Guerin (BCG): The doses contained very low (1.6 x 10 5 cfu), low (3.2 x l0 6 cfu), standard (1.6 x 10 8 cfu), or high (3.2 X 10 8 cfu) levels of BCG. Delayed-type hypersensitivity responses occurred 8 weeks after vaccination in 10% of persons given very low or low doses of BCG, compared with 95% and 100% of persons given standard or high doses, respectively. Lymphoproliferative responses, which were increased only for high-dose vaccinees, peaked 2 weeks after vaccination and were directed chiefly against Mycobacterium tuberculosis-secreted proteins, particularly the antigen 85 complex. Significant increases in mycobacteria-specific interferon-γ expression were present 16 weeks after vaccination only for persons given standard or high doses of BCG. Percutaneous BCG appears capable of inducing a temporary Th1-like immune response, but standard or higher dosages are required.

UR - http://www.scopus.com/inward/record.url?scp=0031817336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031817336&partnerID=8YFLogxK

U2 - 10.1086/515614

DO - 10.1086/515614

M3 - Article

VL - 178

SP - 138

EP - 146

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 1

ER -

Lowry PW, Ludwig TS, Adams JA, Fitzpatrick ML, Grant SM, Andrle GA et al. Cellular immune responses to four doses of percutaneous bacille calmetteguerin in healthy adults. Journal of Infectious Diseases. 1998 Jan 1;178(1):138-146. https://doi.org/10.1086/515614